MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS)
source: myfinsight.com
Download
Download image
Net income (gain)
-$23,708K
(-115.97%↓ Y/Y)
Dividend income
$2,335K
(-65.62%↓ Y/Y)
Income (gain) before
income taxes
-$23,708K
(-114.96%↓ Y/Y)
Total other income,
net
$2,169K
(-66.39%↓ Y/Y)
Service Other
$367K
Other expense, net
-$166K
(50.89%↑ Y/Y)
Income (gain) from
operations
-$25,877K
(-117.02%↓ Y/Y)
Total revenue
$367K
(-99.83%↓ Y/Y)
Total operating
expenses
$26,244K
(-55.67%↓ Y/Y)
Research and development
$16,097K
(-66.95%↓ Y/Y)
General and
administrative
$10,147K
(-3.33%↓ Y/Y)
Back